Changes in Cortical Volumetric Bone Mineral Density and Thickness, and Trabecular Thickness in Lactating Women Postpartum (original) (raw)

Journal Article

,

1Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden

*Address all correspondence and requests for reprints to: Petra Brembeck, MS, Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Box 459, 405 30 Gothenburg, Sweden.

Search for other works by this author on:

,

1Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden

Search for other works by this author on:

,

1Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden

Search for other works by this author on:

,

1Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden

Search for other works by this author on:

1Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden

Search for other works by this author on:

Accepted:

07 November 2014

Published:

01 February 2015

Cite

P. Brembeck, M. Lorentzon, C. Ohlsson, A. Winkvist, H. Augustin, Changes in Cortical Volumetric Bone Mineral Density and Thickness, and Trabecular Thickness in Lactating Women Postpartum, The Journal of Clinical Endocrinology & Metabolism, Volume 100, Issue 2, 1 February 2015, Pages 535–543, https://doi.org/10.1210/jc.2014-2825
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Context:

Lactation is associated with decreased areal bone mineral density (aBMD). Replenishment occurs especially after ceased lactation. Changes in volumetric bone mineral density (vBMD), microstructure, and dimensional parameters are unknown and may clarify the role of lactation for skeletal health.

Objective and Main Outcomes:

The objective of the study was to test the hypothesis that lactation is associated with changes in aBMD, vBMD, microstructure, and dimensional parameters.

Design:

At baseline (0.5 mo after delivery) and 4, 12, and 18 months thereafter, bone was assessed using dual-energy x-ray absorptiometry and high-resolution peripheral quantitative computed tomography.

Participants and Setting:

Eighty-one fair-skinned postpartum women and 21 controls aged 25–40 years were recruited. The completion ratio was 73%. Postpartum women were categorized depending on duration of lactation: 0–3.9, 4–8.9, and 9 months or longer.

Results:

During the first 4 months, aBMD decreased at several sites (geometric mean ± SE; −0.73% ± 0.21% to −3.98% ± 0.76%) in women lactating at least 4 months. During the same time, cortical vBMD at the ultradistal tibia decreased in women lactating 4–8.9 months (−0.26% ± 0.08%) and 9 months or longer (−0.49% ± 0.10%). At 12 months postpartum, cortical thickness (≥9 mo, −2.48% ± 0.41%) and trabecular thickness (4–8.9 mo, −2.14% ± 0.92%; ≥ 9 mo, −2.56% ± 1.21%) also were lower than baseline. No decreases were found in women lactating less than 4 months or in controls in these parameters. At 18 months postpartum, both cortical vBMD (≥9 mo, −0.77% ± 0.17%) and trabecular thickness (4–8.9 mo, −2.25% ± 1.25%; ≥ 9 mo, −3.21% ± 1.41%) were lower in women with long lactation.

Conclusions:

Decreases in cortical vBMD, thickness, and trabecular thickness at the ultradistal tibia were found in women lactating 4 months or longer. Longer follow-up is needed to confirm whether women with extended lactation recover fully or whether the changes could potentially lead to an increased risk of fracture in later life.

Lactation requires substantial amounts of calcium every day. It is estimated that mothers who are fully lactating secrete 200–300 mg/d calcium into their breast milk and some even more (13). Several longitudinal studies have shown a decrease in maternal femoral neck and lumbar spine areal bone mineral density (aBMD) of 2%–6% during the first months of lactation (1, 37), as assessed by dual-energy x-ray absorptiometry (DXA). Furthermore, decreases in aBMD postpartum have been shown to be greater in women with longer duration of lactation, compared with women with a shorter duration of lactation or formula-feeding mothers (1, 35, 810).

Several studies indicate that the influence of lactation varies between different skeletal sites. During the first months of lactation, aBMD is suggested to initially decrease at sites consisting mainly of trabecular bone (35, 11). During extended lactation, a few studies indicate that bone loss is mostly located to the cortical-rich bones (4, 5, 11). It is speculated that a recovery of aBMD at the end of extended lactation or after weaning, therefore, is detected earlier in the trabecular-rich lumbar spine than in the cortical-rich femoral neck (4, 5, 11). Whether aBMD fully recovers after weaning is still not clear. Some studies observed a recovery to baseline (after delivery) 6 months after weaning (5, 1214) and also in women with extended lactation (5, 13, 14). These studies show a decrease in lumbar spine aBMD during the first 9 (5) to 12 (13, 14) months postpartum in women with the longest duration of lactation, which 18 months postpartum was no longer significantly different compared with baseline (5, 13, 14). Furthermore, in Gambian women, periods of long lactation are not associated with consistent decreases in bone minerals (15). Another study, however, does not show a complete recovery at all skeletal sites at 6 months after weaning in women with long duration of lactation (16). Hypothetically, repeated pregnancies and/or long lactations could lead to an increased fracture risk later in life (1, 17). However, several studies show no or even an inverse relation between parity, lactation, and fractures (8, 1820).

In Sweden, a long duration of lactation is common, and at 6 months postpartum, 63% of all infants are breast-fed (21). Therefore, studies of the skeletal recovery after weaning in women with extended lactation require a long follow-up period. Only a few earlier studies have investigated changes in aBMD postpartum in women with an extended lactation and a follow-up period longer than 12 months (5, 13, 14). Of these studies, only Moller et al (5) also included a control group. Inclusion of a comparable group of women who are neither pregnant nor lactating is necessary to handle the variations in increasing age, changes in weight, and possible technical limitations (22).

Most previous studies have used DXA to report changes in aBMD postpartum (1, 35, 14, 1820, 23). Only a two-dimensional areal measurement of the bone is reported by DXA. In addition, DXA does not separate between trabecular and cortical bone. Thus, currently it is not possible to draw conclusions regarding the relation between duration of lactation and changes in trabecular and/or cortical bone. However, the new technique high-resolution peripheral quantitative computed tomography (HR-pQCT) measures volumetric bone mineral density (vBMD) and separates cortical and trabecular bone. Furthermore, HR-pQCT provides information about microstructural changes, such as trabecular thickness and number and trabecular bone volume fraction, and dimensional changes, such as cortical thickness and area. No such data from the postpartum period has previously been published, and thus, changes in vBMD, microstructural and dimensional parameters postpartum, and its clinical implications are unknown. Such information would increase the understanding of skeletal changes during and after lactation. So far, a previous study among postmenopausal women has shown that cortical and trabecular vBMD and cortical thickness are significant determinants of fracture risk (24). The same study showed that HR-pQCT may detect small changes in bone mineral density that are not detectable by DXA (24). This is another advantage of HR-pQCT.

Thus, our aim is to test the hypothesis that lactation is associated with changes not only in aBMD, but also in vBMD, microstructural and dimensional parameters from 2 weeks to 18 months postpartum in fair-skinned women living in Sweden. A control group consisting of nonpregnant and nonlactating fair-skinned women was included in this study.

Subjects and Methods

Subjects

Pregnant and nonpregnant and nonlactating women (controls) were recruited from July 2008 to July 2011 using posters in maternity health care clinics and in public places near Gothenburg, Sweden, and through advertisements on a Swedish web page addressing pregnant women in western Sweden. In total, 81 pregnant women and 21 nonpregnant and nonlactating controls agreed to participate. Inclusion criteria were age 25–40 years and declaring oneself as healthy. Exclusion criteria were intake of prescribed medicine known to effect calcium and bone metabolism, recent bone fractures, pregnancy during the last 1.5 years before current pregnancy/before entering the study as control, miscarriage after week 12 of pregnancy during the last 1.5 years, breast-feeding during the last year before current pregnancy/before entering the study as control, current twin pregnancy, and current development of gestational diabetes or preeclampsia. This study was conducted according to the guidelines laid down in the Declaration of Helsinki (25), and all procedures involving the subjects were approved by the Regional Ethics Committee in Gothenburg and the Swedish Radiation Safety Authority. Written informed consent was obtained from all women.

Study design

All women visited the Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Sweden, at baseline (2 wk after delivery for postpartum women) and 4, 12, and 18 months thereafter. Body weight in underwear was measured (Tanita; BWB-800MA, Rex Frederiksbergs Vaegtfabrik), and height was assessed using a standardized wall stadiometer. Self-reported prepregnancy body weight was recorded. At all visits, women were asked about their lactation status, physical activity level (PAL), and use of hormonal contraceptives. If lactating, detailed information about lactation habits was collected, including the number of lactation sessions per day, number and amount of formula feedings per day, date of introduction of solid foods, and daily amount of solid foods given. Women were asked to record the date of their last lactation. Women were classified as postpartum women or controls. Postpartum women were categorized prior to statistical analyses according to their duration of total lactation; 0–3.9 months, 4–8.9 months, and 9 months or longer. Total lactation refers to any extent of lactation. Full lactation was defined as when 90% or more of the infants' daily energy intake came from breast milk.

Measurements

At all occasions, bone status was measured at the Osteoporotic Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden. The DXA (Lunar Prodigy, GE Lunar Corp; software version 11.400.004) was used to measure aBMD at the ultradistal radius, lumbar spine (L1-L4), femoral neck, femoral shaft, femoral trochanter, total femur, and whole-body. The radius was measured on the nondominant upper limb. The coefficients of variation for the DXA measurements were 0.5%–3%, depending on the measuring site. HR-pQCT (XtremeCT, software version 5.3; Scanco Medical AG) was used to measure cortical vBMD, cortical thickness, cortical area, trabecular vBMD, trabecular thickness, trabecular bone volume fraction, and trabecular number at the ultradistal tibia on the lower limb at the same side as the nondominant radius. Briefly, a reference line was manually placed at the center of the scan of the end plate of the distal tibia. The first computed tomography slice started 22.5 mm proximal to the reference line for the tibia, as previously described (26). Standard evaluations were used. The coefficients of variation were determined from three repeated measurements according to a standardized protocol on two subjects, as previously reported (27). The coefficient of variation ranged from 0.1% to 1.6%: cortical vBMD (0.1%), cortical thickness (0.3%), cortical area (0.4%), trabecular vBMD (0.2%), trabecular thickness (0.7%), trabecular number (1.6%), and trabecular bone volume fraction (0.3%). For long-term precision, we refer to the study by Burghardt et al (28).

Statistical analyses

Comparisons between postpartum women and controls at baseline were made using a Student's t test. Data are presented as mean ± SE, if not otherwise described. Because the data from the DXA and HR-pQCT were not normally distributed, they were log transformed when analyzed. The geometric mean (quartile 1-quartile 3) was used when presenting the means for postpartum women and controls at each time point. Repeated measures were analyzed by linear longitudinal models to study both between- and within-group differences over time. We assumed fixed effects, ie, that the model holds true across the sample, and with the same intercept and slope, we could estimate the outcome. Unstructured covariance structure of our longitudinal data was used. The longitudinal analysis yielded estimates of least square means with SE and P values. The repeated-measures ANOVA from mixed procedure yielded the differences of these least square means and whether these differences were statistically significant. Longitudinal analyses were adjusted for body weight, PAL, age, and use of hormonal contraceptives when significant in the models. Percentage changes in aBMD, vBMD, and microstructural and dimensional parameters were calculated by the difference in log-transformed data between two time points and multiplied by 100. This approximates the percentage change as shown by Cole (29). The significance level was set to P < .05 (two sided). The mixed-procedure, repeated-measures ANOVAs were conducted using SAS for Windows (version 9.2; SAS Institute Inc). All other analyses were conducted using SPSS Statistics Software (version 21.0; IBM).

Results

Descriptive characteristics of postpartum women and controls at baseline are shown in Table 1. Mean self-reported prepregnancy body weight of postpartum women was 64 ± 1 kg. Eighty percent of the postpartum women and 71% of the controls had studied for 3 years or more at the university level. The only descriptive characteristic that differed significantly was body weight at baseline, which was higher for postpartum women compared with controls. The median duration of total lactation was 8.1 months (q1–q3 6.8–10.4 mo, range 0–20.2 mo). The median duration of total lactation within each lactation group was 2.7 months (q1–q3 1.0–3.7 mo) for women lactating 0–3.9 months, 7.6 months (q1–q3 6.8–8.2 mo) for women lactating 4–8.9 months, and 11.8 months (q1–q3 10.1–12.6 mo) for women lactating 9 months or longer.

Table 1.

Descriptive Characteristics of the Participating Women at Baselinea

Postpartum Women (n = 81) Mean (SE) Controls (n = 21) Mean (SE) P Value
Age, y 32.9 (0.4) 32.3 (1.0) .504
Height, cm 168.4 (0.7) 168.9 (1.0) .754
Weight, kg 70.2 (1.0) 64.2 (1.8) .009b
Parity 0.6 (0.1) 0.7 (0.4) .867
aBMD, g/m2
Radius ultradistal 0.334 (0.306–0.372) 0.348 (0.317–0.368) .230
Lumbar spine 1.167 (1.080–1.252) 1.209 (1.105–1.300) .210
Femoral neck 0.993 (0.920–1.072) 1.009 (0.928–1.101) .647
Femoral shaft 1.204 (1.091–1.309) 1.202 (1.149–1.260) .828
Femoral trochanter 0.783 (0.710–0.866) 0.775 (0.696–0.863) .736
Total femur 1.012 (0.913–1.090) 1.011 (0.935–1.039) .884
Whole body 1.180 (1.131–1.232) 1.195 (1.151–1.246) .472
Cortical vBMD, mg/cm3 892.5 (867.8–918.7) 906.3 (893.4–942.0) .135
Cortical thickness, mm 1.134 (0.977–1.300) 1.158 (1.000–1.489) .751
Cortical area, mm2 117.6 (106.6–132.0) 118.2 (106.1–133.4) .993
Trabecular vBMD, mg/cm3 156.9 (133.0–177.5) 164.4 (151.3–172.3) .445
Trabecular thickness, mm 0.070 (0.060–0.079) 0.074 (0.066–0.084) .249
Trabecular number, mm−1 1.860 (1.696–2.016) 1.849 (1.680–2.020) .896
Trabecular bone volume fraction 0.131 (0.111–0.148) 0.137 (0.126–0.144) .450
Postpartum Women (n = 81) Mean (SE) Controls (n = 21) Mean (SE) P Value
Age, y 32.9 (0.4) 32.3 (1.0) .504
Height, cm 168.4 (0.7) 168.9 (1.0) .754
Weight, kg 70.2 (1.0) 64.2 (1.8) .009b
Parity 0.6 (0.1) 0.7 (0.4) .867
aBMD, g/m2
Radius ultradistal 0.334 (0.306–0.372) 0.348 (0.317–0.368) .230
Lumbar spine 1.167 (1.080–1.252) 1.209 (1.105–1.300) .210
Femoral neck 0.993 (0.920–1.072) 1.009 (0.928–1.101) .647
Femoral shaft 1.204 (1.091–1.309) 1.202 (1.149–1.260) .828
Femoral trochanter 0.783 (0.710–0.866) 0.775 (0.696–0.863) .736
Total femur 1.012 (0.913–1.090) 1.011 (0.935–1.039) .884
Whole body 1.180 (1.131–1.232) 1.195 (1.151–1.246) .472
Cortical vBMD, mg/cm3 892.5 (867.8–918.7) 906.3 (893.4–942.0) .135
Cortical thickness, mm 1.134 (0.977–1.300) 1.158 (1.000–1.489) .751
Cortical area, mm2 117.6 (106.6–132.0) 118.2 (106.1–133.4) .993
Trabecular vBMD, mg/cm3 156.9 (133.0–177.5) 164.4 (151.3–172.3) .445
Trabecular thickness, mm 0.070 (0.060–0.079) 0.074 (0.066–0.084) .249
Trabecular number, mm−1 1.860 (1.696–2.016) 1.849 (1.680–2.020) .896
Trabecular bone volume fraction 0.131 (0.111–0.148) 0.137 (0.126–0.144) .450

Statistical analyses for comparisons between postpartum women and controls were performed with a Student's t test. For all bone parameters, geometric means (quartiles 1–3) are shown.

a

Two weeks after delivery.

b

Significant difference between postpartum women and controls.

Table 1.

Descriptive Characteristics of the Participating Women at Baselinea

Postpartum Women (n = 81) Mean (SE) Controls (n = 21) Mean (SE) P Value
Age, y 32.9 (0.4) 32.3 (1.0) .504
Height, cm 168.4 (0.7) 168.9 (1.0) .754
Weight, kg 70.2 (1.0) 64.2 (1.8) .009b
Parity 0.6 (0.1) 0.7 (0.4) .867
aBMD, g/m2
Radius ultradistal 0.334 (0.306–0.372) 0.348 (0.317–0.368) .230
Lumbar spine 1.167 (1.080–1.252) 1.209 (1.105–1.300) .210
Femoral neck 0.993 (0.920–1.072) 1.009 (0.928–1.101) .647
Femoral shaft 1.204 (1.091–1.309) 1.202 (1.149–1.260) .828
Femoral trochanter 0.783 (0.710–0.866) 0.775 (0.696–0.863) .736
Total femur 1.012 (0.913–1.090) 1.011 (0.935–1.039) .884
Whole body 1.180 (1.131–1.232) 1.195 (1.151–1.246) .472
Cortical vBMD, mg/cm3 892.5 (867.8–918.7) 906.3 (893.4–942.0) .135
Cortical thickness, mm 1.134 (0.977–1.300) 1.158 (1.000–1.489) .751
Cortical area, mm2 117.6 (106.6–132.0) 118.2 (106.1–133.4) .993
Trabecular vBMD, mg/cm3 156.9 (133.0–177.5) 164.4 (151.3–172.3) .445
Trabecular thickness, mm 0.070 (0.060–0.079) 0.074 (0.066–0.084) .249
Trabecular number, mm−1 1.860 (1.696–2.016) 1.849 (1.680–2.020) .896
Trabecular bone volume fraction 0.131 (0.111–0.148) 0.137 (0.126–0.144) .450
Postpartum Women (n = 81) Mean (SE) Controls (n = 21) Mean (SE) P Value
Age, y 32.9 (0.4) 32.3 (1.0) .504
Height, cm 168.4 (0.7) 168.9 (1.0) .754
Weight, kg 70.2 (1.0) 64.2 (1.8) .009b
Parity 0.6 (0.1) 0.7 (0.4) .867
aBMD, g/m2
Radius ultradistal 0.334 (0.306–0.372) 0.348 (0.317–0.368) .230
Lumbar spine 1.167 (1.080–1.252) 1.209 (1.105–1.300) .210
Femoral neck 0.993 (0.920–1.072) 1.009 (0.928–1.101) .647
Femoral shaft 1.204 (1.091–1.309) 1.202 (1.149–1.260) .828
Femoral trochanter 0.783 (0.710–0.866) 0.775 (0.696–0.863) .736
Total femur 1.012 (0.913–1.090) 1.011 (0.935–1.039) .884
Whole body 1.180 (1.131–1.232) 1.195 (1.151–1.246) .472
Cortical vBMD, mg/cm3 892.5 (867.8–918.7) 906.3 (893.4–942.0) .135
Cortical thickness, mm 1.134 (0.977–1.300) 1.158 (1.000–1.489) .751
Cortical area, mm2 117.6 (106.6–132.0) 118.2 (106.1–133.4) .993
Trabecular vBMD, mg/cm3 156.9 (133.0–177.5) 164.4 (151.3–172.3) .445
Trabecular thickness, mm 0.070 (0.060–0.079) 0.074 (0.066–0.084) .249
Trabecular number, mm−1 1.860 (1.696–2.016) 1.849 (1.680–2.020) .896
Trabecular bone volume fraction 0.131 (0.111–0.148) 0.137 (0.126–0.144) .450

Statistical analyses for comparisons between postpartum women and controls were performed with a Student's t test. For all bone parameters, geometric means (quartiles 1–3) are shown.

a

Two weeks after delivery.

b

Significant difference between postpartum women and controls.

The percentage of postpartum women using hormonal contraceptives 0.5, 4, 12, and 18 months postpartum were 0%, 27%, 30%, and 31%, respectively. Corresponding percentage of controls were 52%, 48%, 58%, and 41%, respectively. Numbers of postpartum women and controls with a full set of data were, respectively, at 4 months postpartum 81 and 21 women, at 12 months postpartum 79 and 19 women, and at 18 months postpartum 58 and 18 women (see Table 2). Reasons for leaving the study were a new pregnancy (n = 17), time constraint (n = 8), and the development of disease (n = 3). Two of these three women were excluded from the analyses from the time point when they started their medication. The third women was excluded due to the potential development of osteoporosis. Because of a high dropout rate between 12 and 18 months postpartum in the group lactating 0–3.9 months, the measurement at 18 months postpartum was excluded from the analyses for this lactation group.

Table 2.

Mean Percentage Change ± SE in aBMD Compared With Baseline,a as Assessed With DXA

Percentage Change in aBMD (g/cm2) Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Radius ultradistalb
4 mo postpartum 0.70 ± 1.48 −0.35 ± 0.62 −1.54 ± 0.73 −1.09 ± 0.81
12 mo postpartum 2.10 ± 1.37c −1.82 ± 0.73 −2.65 ± 0.88 −0.04 ± 1.19
18 mo postpartumd 0.91 ± 0.73c −1.82 ± 1.36 −0.19 ± 1.01
Lumbar spineb
4 mo postpartum −0.16 ± 1.41 −3.71 ± 0.53e −3.98 ± 0.76e −0.23 ± 0.36
12 mo postpartum 3.88 ± 0.94e 1.91 ± 0.61e −0.76 ± 0.71 0.31 ± 0.38
18 mo postpartum 4.27 ± 0.65e 2.30 ± 0.69c 0.33 ± 0.48
Femoral neckb,f
4 mo postpartum −1.45 ± 0.98 −3.80 ± 0.40e −3.98 ± 0.66e −0.27 ± 0.47
12 mo postpartum −1.02 ± 1.25 −2.92 ± 0.60c −4.00 ± 0.69e −0.21 ± 0.56
18 mo postpartum −1.60 ± 0.70 −2.28 ± 0.89 −0.48 ± 0.56
Femoral shaftf,g
4 mo postpartum 0.05 ± 0.54 −3.12 ± 0.34e −3.01 ± 0.44e 0.48 ± 0.49
12 mo postpartum 1.47 ± 0.81h −1.23 ± 0.40h −3.15 ± 0.59e 0.66 ± 0.63
18 mo postpartum 0.59 ± 0.51 −0.53 ± 0.68 0.50 ± 0.66
Femoral trochanter
4 mo postpartum 1.65 ± 0.56 −2.57 ± 0.39e −2.85 ± 0.65e −0.73 ± 0.57
12 mo postpartum 2.01 ± 1.04 −0.09 ± 0.58 −2.19 ± 0.78c −0.38 ± 0.75
18 mo postpartum 1.92 ± 0.72c 1.35 ± 0.89 −0.52 ± 0.61
Total femurf
4 mo postpartum 0.31 ± 0.55 −2.98 ± 0.31e −2.93 ± 0.47e 0.09 ± 0.29
12 mo postpartum 1.42 ± 0.77 −1.05 ± 0.44h −2.89 ± 0.56e 0.26 ± 0.37
18 mo postpartum 0.77 ± 0.52 −0.13 ± 0.64 0.15 ± 0.39
Whole body
4 mo postpartum 0.63 ± 0.46 −0.73 ± 0.21c −0.84 ± 0.30c −0.23 ± 0.38
12 mo postpartum 0.19 ± 0.41 −0.06 ± 0.33 −1.58 ± 0.38e 0.36 ± 0.41
18 mo postpartum 0.54 ± 0.37 −0.14 ± 0.40 0.41 ± 0.55
Percentage Change in aBMD (g/cm2) Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Radius ultradistalb
4 mo postpartum 0.70 ± 1.48 −0.35 ± 0.62 −1.54 ± 0.73 −1.09 ± 0.81
12 mo postpartum 2.10 ± 1.37c −1.82 ± 0.73 −2.65 ± 0.88 −0.04 ± 1.19
18 mo postpartumd 0.91 ± 0.73c −1.82 ± 1.36 −0.19 ± 1.01
Lumbar spineb
4 mo postpartum −0.16 ± 1.41 −3.71 ± 0.53e −3.98 ± 0.76e −0.23 ± 0.36
12 mo postpartum 3.88 ± 0.94e 1.91 ± 0.61e −0.76 ± 0.71 0.31 ± 0.38
18 mo postpartum 4.27 ± 0.65e 2.30 ± 0.69c 0.33 ± 0.48
Femoral neckb,f
4 mo postpartum −1.45 ± 0.98 −3.80 ± 0.40e −3.98 ± 0.66e −0.27 ± 0.47
12 mo postpartum −1.02 ± 1.25 −2.92 ± 0.60c −4.00 ± 0.69e −0.21 ± 0.56
18 mo postpartum −1.60 ± 0.70 −2.28 ± 0.89 −0.48 ± 0.56
Femoral shaftf,g
4 mo postpartum 0.05 ± 0.54 −3.12 ± 0.34e −3.01 ± 0.44e 0.48 ± 0.49
12 mo postpartum 1.47 ± 0.81h −1.23 ± 0.40h −3.15 ± 0.59e 0.66 ± 0.63
18 mo postpartum 0.59 ± 0.51 −0.53 ± 0.68 0.50 ± 0.66
Femoral trochanter
4 mo postpartum 1.65 ± 0.56 −2.57 ± 0.39e −2.85 ± 0.65e −0.73 ± 0.57
12 mo postpartum 2.01 ± 1.04 −0.09 ± 0.58 −2.19 ± 0.78c −0.38 ± 0.75
18 mo postpartum 1.92 ± 0.72c 1.35 ± 0.89 −0.52 ± 0.61
Total femurf
4 mo postpartum 0.31 ± 0.55 −2.98 ± 0.31e −2.93 ± 0.47e 0.09 ± 0.29
12 mo postpartum 1.42 ± 0.77 −1.05 ± 0.44h −2.89 ± 0.56e 0.26 ± 0.37
18 mo postpartum 0.77 ± 0.52 −0.13 ± 0.64 0.15 ± 0.39
Whole body
4 mo postpartum 0.63 ± 0.46 −0.73 ± 0.21c −0.84 ± 0.30c −0.23 ± 0.38
12 mo postpartum 0.19 ± 0.41 −0.06 ± 0.33 −1.58 ± 0.38e 0.36 ± 0.41
18 mo postpartum 0.54 ± 0.37 −0.14 ± 0.40 0.41 ± 0.55

Statistical analyses were performed with mixed-procedure, repeated-measure ANOVAs with least square means. The confounders body weight, physical activity level, age, and use of hormonal contraceptives were adjusted for if significant in the analyses.

a

Two weeks after delivery.

b

Adjusted for body weight.

c

P < .01, compared with baseline.

d

Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

e

P < .001, compared with baseline.

f

Adjusted for age.

g

Adjusted for use of hormonal contraceptives.

h

P < .05, compared with baseline.

Table 2.

Mean Percentage Change ± SE in aBMD Compared With Baseline,a as Assessed With DXA

Percentage Change in aBMD (g/cm2) Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Radius ultradistalb
4 mo postpartum 0.70 ± 1.48 −0.35 ± 0.62 −1.54 ± 0.73 −1.09 ± 0.81
12 mo postpartum 2.10 ± 1.37c −1.82 ± 0.73 −2.65 ± 0.88 −0.04 ± 1.19
18 mo postpartumd 0.91 ± 0.73c −1.82 ± 1.36 −0.19 ± 1.01
Lumbar spineb
4 mo postpartum −0.16 ± 1.41 −3.71 ± 0.53e −3.98 ± 0.76e −0.23 ± 0.36
12 mo postpartum 3.88 ± 0.94e 1.91 ± 0.61e −0.76 ± 0.71 0.31 ± 0.38
18 mo postpartum 4.27 ± 0.65e 2.30 ± 0.69c 0.33 ± 0.48
Femoral neckb,f
4 mo postpartum −1.45 ± 0.98 −3.80 ± 0.40e −3.98 ± 0.66e −0.27 ± 0.47
12 mo postpartum −1.02 ± 1.25 −2.92 ± 0.60c −4.00 ± 0.69e −0.21 ± 0.56
18 mo postpartum −1.60 ± 0.70 −2.28 ± 0.89 −0.48 ± 0.56
Femoral shaftf,g
4 mo postpartum 0.05 ± 0.54 −3.12 ± 0.34e −3.01 ± 0.44e 0.48 ± 0.49
12 mo postpartum 1.47 ± 0.81h −1.23 ± 0.40h −3.15 ± 0.59e 0.66 ± 0.63
18 mo postpartum 0.59 ± 0.51 −0.53 ± 0.68 0.50 ± 0.66
Femoral trochanter
4 mo postpartum 1.65 ± 0.56 −2.57 ± 0.39e −2.85 ± 0.65e −0.73 ± 0.57
12 mo postpartum 2.01 ± 1.04 −0.09 ± 0.58 −2.19 ± 0.78c −0.38 ± 0.75
18 mo postpartum 1.92 ± 0.72c 1.35 ± 0.89 −0.52 ± 0.61
Total femurf
4 mo postpartum 0.31 ± 0.55 −2.98 ± 0.31e −2.93 ± 0.47e 0.09 ± 0.29
12 mo postpartum 1.42 ± 0.77 −1.05 ± 0.44h −2.89 ± 0.56e 0.26 ± 0.37
18 mo postpartum 0.77 ± 0.52 −0.13 ± 0.64 0.15 ± 0.39
Whole body
4 mo postpartum 0.63 ± 0.46 −0.73 ± 0.21c −0.84 ± 0.30c −0.23 ± 0.38
12 mo postpartum 0.19 ± 0.41 −0.06 ± 0.33 −1.58 ± 0.38e 0.36 ± 0.41
18 mo postpartum 0.54 ± 0.37 −0.14 ± 0.40 0.41 ± 0.55
Percentage Change in aBMD (g/cm2) Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Radius ultradistalb
4 mo postpartum 0.70 ± 1.48 −0.35 ± 0.62 −1.54 ± 0.73 −1.09 ± 0.81
12 mo postpartum 2.10 ± 1.37c −1.82 ± 0.73 −2.65 ± 0.88 −0.04 ± 1.19
18 mo postpartumd 0.91 ± 0.73c −1.82 ± 1.36 −0.19 ± 1.01
Lumbar spineb
4 mo postpartum −0.16 ± 1.41 −3.71 ± 0.53e −3.98 ± 0.76e −0.23 ± 0.36
12 mo postpartum 3.88 ± 0.94e 1.91 ± 0.61e −0.76 ± 0.71 0.31 ± 0.38
18 mo postpartum 4.27 ± 0.65e 2.30 ± 0.69c 0.33 ± 0.48
Femoral neckb,f
4 mo postpartum −1.45 ± 0.98 −3.80 ± 0.40e −3.98 ± 0.66e −0.27 ± 0.47
12 mo postpartum −1.02 ± 1.25 −2.92 ± 0.60c −4.00 ± 0.69e −0.21 ± 0.56
18 mo postpartum −1.60 ± 0.70 −2.28 ± 0.89 −0.48 ± 0.56
Femoral shaftf,g
4 mo postpartum 0.05 ± 0.54 −3.12 ± 0.34e −3.01 ± 0.44e 0.48 ± 0.49
12 mo postpartum 1.47 ± 0.81h −1.23 ± 0.40h −3.15 ± 0.59e 0.66 ± 0.63
18 mo postpartum 0.59 ± 0.51 −0.53 ± 0.68 0.50 ± 0.66
Femoral trochanter
4 mo postpartum 1.65 ± 0.56 −2.57 ± 0.39e −2.85 ± 0.65e −0.73 ± 0.57
12 mo postpartum 2.01 ± 1.04 −0.09 ± 0.58 −2.19 ± 0.78c −0.38 ± 0.75
18 mo postpartum 1.92 ± 0.72c 1.35 ± 0.89 −0.52 ± 0.61
Total femurf
4 mo postpartum 0.31 ± 0.55 −2.98 ± 0.31e −2.93 ± 0.47e 0.09 ± 0.29
12 mo postpartum 1.42 ± 0.77 −1.05 ± 0.44h −2.89 ± 0.56e 0.26 ± 0.37
18 mo postpartum 0.77 ± 0.52 −0.13 ± 0.64 0.15 ± 0.39
Whole body
4 mo postpartum 0.63 ± 0.46 −0.73 ± 0.21c −0.84 ± 0.30c −0.23 ± 0.38
12 mo postpartum 0.19 ± 0.41 −0.06 ± 0.33 −1.58 ± 0.38e 0.36 ± 0.41
18 mo postpartum 0.54 ± 0.37 −0.14 ± 0.40 0.41 ± 0.55

Statistical analyses were performed with mixed-procedure, repeated-measure ANOVAs with least square means. The confounders body weight, physical activity level, age, and use of hormonal contraceptives were adjusted for if significant in the analyses.

a

Two weeks after delivery.

b

Adjusted for body weight.

c

P < .01, compared with baseline.

d

Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

e

P < .001, compared with baseline.

f

Adjusted for age.

g

Adjusted for use of hormonal contraceptives.

h

P < .05, compared with baseline.

Mixed-procedure, repeated-measures ANOVAs showed significant differences in change over time in aBMD between postpartum women and controls at the lumbar spine, femoral neck, shaft, and trochanter and total femur (P < .001 for all sites) (Supplemental Table 1). Body weight, age, and the use of hormonal contraceptives remained as significant confounders in the longitudinal analyses of changes in aBMD at some sites (Supplemental Tables 1 and 2), whereas PAL did not. When grouping the women according to the duration of total lactation (0–3.9 mo, 4–8.9 mo, ≥ 9 mo, and controls), repeated-measures ANOVAs showed that decreases in aBMD were significant only in the groups lactating 4–8.9 months and 9 months or longer. During the first 4 months postpartum, these two lactation groups had significant decreases in aBMD in the range −0.73% ± 0.21% to −3.98% ± 0.76% at the lumbar spine, femoral neck, shaft and trochanter, total femur, and whole body as compared with baseline (Table 2). At 12 months postpartum, aBMD at femoral neck, shaft, and total femur were still significantly lower in women lactating 4–8.9 months and 9 months or longer compared with baseline, as well as femoral trochanter and whole body for women lactating 9 months or longer. For women lactating 4–8.9 months, aBMD at the lumbar spine was instead significantly higher than baseline at 12 months postpartum. For women with a short duration of lactation (0–3.9 mo), aBMD at the lumbar spine and radius ultradistal was also significantly higher compared with baseline at 12 months postpartum (Table 2).

At 18 months postpartum, aBMD at the lumbar spine was significantly higher than baseline for women lactating both 4–8.9 months and 9 months or longer, as well as the femoral trochanter and radius ultradistal for women lactating 4–8.9 months (Table 2). No significant decreases compared with baseline were found at 18 months postpartum in any lactation group. No significant changes were found in controls at any time point.

Mixed-procedure, repeated-measures ANOVAs revealed significant differences in change over time at the ultradistal tibia bone parameters between postpartum women and controls in cortical thickness (P = .011), cortical area (P = .005), trabecular bone volume fraction (P = .044), and trabecular vBMD (P = .049) (Supplemental Table 2). No confounders were found. Repeated-measures ANOVAs showed significant decreases only in women with a long duration of lactation (4–8.9 and ≥ 9 mo) for cortical vBMD (−0.26% ± 0.08% and −0.49% ± 0.10%) and cortical area (−0.71% ± 0.24% and −1.54% ± 0.33%) during the first 4 months postpartum at the tibia (Table 3). In women lactating 4–8.9 months, significant decreases compared with baseline were also evident for cortical thickness (−2.46% ± 1.63%) and trabecular bone volume fraction (−0.66% ± 0.38%). No changes were found in women with a short duration of lactation (0–3.9 mo). In controls, significant changes were found only in the trabecular vBMD (−1.03% ± 0.35%) and trabecular bone volume fraction (−1.12% ± 0.37%) during the first 4 months, as compared with baseline.

Table 3.

Mean Percentage Change ± SE in Tibia Bone Parameters Compared With Baseline,a as Assessed With HR-pQCT

Percentage Change Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Cortical vBMD, mg/cm3
4 mo postpartum 0.29 ± 0.18 −0.26 ± 0.08b −0.49 ± 0.10c −0.13 ± 0.09
12 mo postpartum 0.24 ± 0.20 −0.38 ± 0.15b −1.24 ± 0.16c −0.23 ± 0.12
18 mo postpartumd −0.02 ± 0.18 −0.77 ± 0.17c −0.27 ± 0.11
Cortical thickness, mm
4 mo postpartum 0.71 ± 0.57 −2.46 ± 1.63e −1.52 ± 0.33 −0.17 ± 0.18
12 mo postpartum 1.04 ± 0.74 −0.15 ± 0.46 −2.48 ± 0.41c 0.22 ± 0.40
18 mo postpartum 1.90 ± 0.57c −0.70 ± 0.46 0.38 ± 0.37
Cortical area, mm2
4 mo postpartum 0.44 ± 0.48 −0.71 ± 0.24b −1.54 ± 0.33c −0.01 ± 0.16
12 mo postpartum 0.79 ± 0.66 −0.04 ± 0.45 −2.49 ± 0.41c 0.27 ± 0.36
18 mo postpartum 1.99 ± 0.57c −0.59 ± 0.46 0.40 ± 0.32
Trabecular vBMD, mg/cm3
4 mo postpartum 0.12 ± 0.43 −0.55 ± 0.39 −0.49 ± 0.32 −1.03 ± 0.35d
12 mo postpartum −0.55 ± 0.83 −1.14 ± 0.76 −2.57 ± 0.72b −1.81 ± 0.76
18 mo postpartum −0.03 ± 0.94 −1.00 ± 0.88 −2.38 ± 0.81e
Trabecular thickness, mm
4 mo postpartum 1.88 ± 2.52 −1.35 ± 0.82 −1.89 ± 0.98 0.09 ± 1.79
12 mo postpartum −0.08 ± 1.65 −2.14 ± 0.92e −2.56 ± 1.21e −0.36 ± 1.64
18 mo postpartum −2.25 ± 1.25e −3.21 ± 1.41e −1.60 ± 2.03
Trabecular number, mm−1
4 mo postpartum −1.53 ± 2.57 0.92 ± 0.78 1.42 ± 1.04 −1.28 ± 1.77
12 mo postpartum 0.17 ± 1.59 0.96 ± 0.70 −0.17 ± 1.18 −1.53 ± 1.56
18 mo postpartum 2.31 ± 1.06e 2.21 ± 1.09 −0.84 ± 2.02
Trabecular bone volume fraction
4 mo postpartum 0.20 ± 0.37 −0.66 ± 0.38e −0.52 ± 0.32 −1.12 ± 0.37e
12 mo postpartum −0.43 ± 0.84 −1.15 ± 0.77 −2.60 ± 0.70b −1.85 ± 0.77
18 mo postpartum 0.00 ± 0.93 −0.92 ± 0.90 −2.45 ± 0.83e
Percentage Change Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Cortical vBMD, mg/cm3
4 mo postpartum 0.29 ± 0.18 −0.26 ± 0.08b −0.49 ± 0.10c −0.13 ± 0.09
12 mo postpartum 0.24 ± 0.20 −0.38 ± 0.15b −1.24 ± 0.16c −0.23 ± 0.12
18 mo postpartumd −0.02 ± 0.18 −0.77 ± 0.17c −0.27 ± 0.11
Cortical thickness, mm
4 mo postpartum 0.71 ± 0.57 −2.46 ± 1.63e −1.52 ± 0.33 −0.17 ± 0.18
12 mo postpartum 1.04 ± 0.74 −0.15 ± 0.46 −2.48 ± 0.41c 0.22 ± 0.40
18 mo postpartum 1.90 ± 0.57c −0.70 ± 0.46 0.38 ± 0.37
Cortical area, mm2
4 mo postpartum 0.44 ± 0.48 −0.71 ± 0.24b −1.54 ± 0.33c −0.01 ± 0.16
12 mo postpartum 0.79 ± 0.66 −0.04 ± 0.45 −2.49 ± 0.41c 0.27 ± 0.36
18 mo postpartum 1.99 ± 0.57c −0.59 ± 0.46 0.40 ± 0.32
Trabecular vBMD, mg/cm3
4 mo postpartum 0.12 ± 0.43 −0.55 ± 0.39 −0.49 ± 0.32 −1.03 ± 0.35d
12 mo postpartum −0.55 ± 0.83 −1.14 ± 0.76 −2.57 ± 0.72b −1.81 ± 0.76
18 mo postpartum −0.03 ± 0.94 −1.00 ± 0.88 −2.38 ± 0.81e
Trabecular thickness, mm
4 mo postpartum 1.88 ± 2.52 −1.35 ± 0.82 −1.89 ± 0.98 0.09 ± 1.79
12 mo postpartum −0.08 ± 1.65 −2.14 ± 0.92e −2.56 ± 1.21e −0.36 ± 1.64
18 mo postpartum −2.25 ± 1.25e −3.21 ± 1.41e −1.60 ± 2.03
Trabecular number, mm−1
4 mo postpartum −1.53 ± 2.57 0.92 ± 0.78 1.42 ± 1.04 −1.28 ± 1.77
12 mo postpartum 0.17 ± 1.59 0.96 ± 0.70 −0.17 ± 1.18 −1.53 ± 1.56
18 mo postpartum 2.31 ± 1.06e 2.21 ± 1.09 −0.84 ± 2.02
Trabecular bone volume fraction
4 mo postpartum 0.20 ± 0.37 −0.66 ± 0.38e −0.52 ± 0.32 −1.12 ± 0.37e
12 mo postpartum −0.43 ± 0.84 −1.15 ± 0.77 −2.60 ± 0.70b −1.85 ± 0.77
18 mo postpartum 0.00 ± 0.93 −0.92 ± 0.90 −2.45 ± 0.83e

Statistical analyses were performed with mixed-procedure, repeated-measure ANOVAs with least square means. Body weight, physical activity level, age, and use of hormonal contraceptives were not significant as confounders in the analyses.

a

Two weeks after delivery.

b

P < .01, compared with baseline.

c

P < .001, compared with baseline.

d

Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

e

P < .05, compared with baseline.

Table 3.

Mean Percentage Change ± SE in Tibia Bone Parameters Compared With Baseline,a as Assessed With HR-pQCT

Percentage Change Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Cortical vBMD, mg/cm3
4 mo postpartum 0.29 ± 0.18 −0.26 ± 0.08b −0.49 ± 0.10c −0.13 ± 0.09
12 mo postpartum 0.24 ± 0.20 −0.38 ± 0.15b −1.24 ± 0.16c −0.23 ± 0.12
18 mo postpartumd −0.02 ± 0.18 −0.77 ± 0.17c −0.27 ± 0.11
Cortical thickness, mm
4 mo postpartum 0.71 ± 0.57 −2.46 ± 1.63e −1.52 ± 0.33 −0.17 ± 0.18
12 mo postpartum 1.04 ± 0.74 −0.15 ± 0.46 −2.48 ± 0.41c 0.22 ± 0.40
18 mo postpartum 1.90 ± 0.57c −0.70 ± 0.46 0.38 ± 0.37
Cortical area, mm2
4 mo postpartum 0.44 ± 0.48 −0.71 ± 0.24b −1.54 ± 0.33c −0.01 ± 0.16
12 mo postpartum 0.79 ± 0.66 −0.04 ± 0.45 −2.49 ± 0.41c 0.27 ± 0.36
18 mo postpartum 1.99 ± 0.57c −0.59 ± 0.46 0.40 ± 0.32
Trabecular vBMD, mg/cm3
4 mo postpartum 0.12 ± 0.43 −0.55 ± 0.39 −0.49 ± 0.32 −1.03 ± 0.35d
12 mo postpartum −0.55 ± 0.83 −1.14 ± 0.76 −2.57 ± 0.72b −1.81 ± 0.76
18 mo postpartum −0.03 ± 0.94 −1.00 ± 0.88 −2.38 ± 0.81e
Trabecular thickness, mm
4 mo postpartum 1.88 ± 2.52 −1.35 ± 0.82 −1.89 ± 0.98 0.09 ± 1.79
12 mo postpartum −0.08 ± 1.65 −2.14 ± 0.92e −2.56 ± 1.21e −0.36 ± 1.64
18 mo postpartum −2.25 ± 1.25e −3.21 ± 1.41e −1.60 ± 2.03
Trabecular number, mm−1
4 mo postpartum −1.53 ± 2.57 0.92 ± 0.78 1.42 ± 1.04 −1.28 ± 1.77
12 mo postpartum 0.17 ± 1.59 0.96 ± 0.70 −0.17 ± 1.18 −1.53 ± 1.56
18 mo postpartum 2.31 ± 1.06e 2.21 ± 1.09 −0.84 ± 2.02
Trabecular bone volume fraction
4 mo postpartum 0.20 ± 0.37 −0.66 ± 0.38e −0.52 ± 0.32 −1.12 ± 0.37e
12 mo postpartum −0.43 ± 0.84 −1.15 ± 0.77 −2.60 ± 0.70b −1.85 ± 0.77
18 mo postpartum 0.00 ± 0.93 −0.92 ± 0.90 −2.45 ± 0.83e
Percentage Change Compared With Baseline Duration of Lactation
0–3.9 Months 4–8.9 Months ≥ 9 Months Controls
4 mo postpartum, n 10 42 29 21
12 mo postpartum, n 10 41 28 19
18 mo postpartum, n 2 34 22 18
Cortical vBMD, mg/cm3
4 mo postpartum 0.29 ± 0.18 −0.26 ± 0.08b −0.49 ± 0.10c −0.13 ± 0.09
12 mo postpartum 0.24 ± 0.20 −0.38 ± 0.15b −1.24 ± 0.16c −0.23 ± 0.12
18 mo postpartumd −0.02 ± 0.18 −0.77 ± 0.17c −0.27 ± 0.11
Cortical thickness, mm
4 mo postpartum 0.71 ± 0.57 −2.46 ± 1.63e −1.52 ± 0.33 −0.17 ± 0.18
12 mo postpartum 1.04 ± 0.74 −0.15 ± 0.46 −2.48 ± 0.41c 0.22 ± 0.40
18 mo postpartum 1.90 ± 0.57c −0.70 ± 0.46 0.38 ± 0.37
Cortical area, mm2
4 mo postpartum 0.44 ± 0.48 −0.71 ± 0.24b −1.54 ± 0.33c −0.01 ± 0.16
12 mo postpartum 0.79 ± 0.66 −0.04 ± 0.45 −2.49 ± 0.41c 0.27 ± 0.36
18 mo postpartum 1.99 ± 0.57c −0.59 ± 0.46 0.40 ± 0.32
Trabecular vBMD, mg/cm3
4 mo postpartum 0.12 ± 0.43 −0.55 ± 0.39 −0.49 ± 0.32 −1.03 ± 0.35d
12 mo postpartum −0.55 ± 0.83 −1.14 ± 0.76 −2.57 ± 0.72b −1.81 ± 0.76
18 mo postpartum −0.03 ± 0.94 −1.00 ± 0.88 −2.38 ± 0.81e
Trabecular thickness, mm
4 mo postpartum 1.88 ± 2.52 −1.35 ± 0.82 −1.89 ± 0.98 0.09 ± 1.79
12 mo postpartum −0.08 ± 1.65 −2.14 ± 0.92e −2.56 ± 1.21e −0.36 ± 1.64
18 mo postpartum −2.25 ± 1.25e −3.21 ± 1.41e −1.60 ± 2.03
Trabecular number, mm−1
4 mo postpartum −1.53 ± 2.57 0.92 ± 0.78 1.42 ± 1.04 −1.28 ± 1.77
12 mo postpartum 0.17 ± 1.59 0.96 ± 0.70 −0.17 ± 1.18 −1.53 ± 1.56
18 mo postpartum 2.31 ± 1.06e 2.21 ± 1.09 −0.84 ± 2.02
Trabecular bone volume fraction
4 mo postpartum 0.20 ± 0.37 −0.66 ± 0.38e −0.52 ± 0.32 −1.12 ± 0.37e
12 mo postpartum −0.43 ± 0.84 −1.15 ± 0.77 −2.60 ± 0.70b −1.85 ± 0.77
18 mo postpartum 0.00 ± 0.93 −0.92 ± 0.90 −2.45 ± 0.83e

Statistical analyses were performed with mixed-procedure, repeated-measure ANOVAs with least square means. Body weight, physical activity level, age, and use of hormonal contraceptives were not significant as confounders in the analyses.

a

Two weeks after delivery.

b

P < .01, compared with baseline.

c

P < .001, compared with baseline.

d

Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

e

P < .05, compared with baseline.

At 12 months postpartum, significant decreases compared with baseline were still evident for women lactating 4–8.9 and 9 months or longer in cortical vBMD (−0.38% ± 0.15% and −1.24% ± 0.16%) (Figure 1) and also in trabecular thickness (−2.14% ± 0.92% and −2.56% ± 1.21%). In women lactating 9 months or longer, significant decreases at 12 months postpartum compared with baseline were further evident for cortical thickness (−2.48% ± 0.41%) (Figure 2), cortical area (−2.49% ± 0.41%), trabecular vBMD (−2.57% ± 0.72%), and trabecular bone volume fraction (−2.60% ± 0.70%). No significant changes were found in women with a short duration of lactation (0–3.9 mo) or in controls at 12 months postpartum, as compared with baseline.

Mean percentage change from baseline ± SE in cortical vBMD at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to duration of total lactation.

Figure 1.

Mean percentage change from baseline ± SE in cortical vBMD at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to duration of total lactation.

*, Significant change compared with baseline for lactation groups 4–8.9 months and 9 months or longer; §, significant change compared with baseline for lactation groups 4–8.9 months and 9 months or longer; ‡, significant change compared with baseline for lactation group 9 months or longer. a, Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

Mean percentage change from baseline ± SE in cortical thickness at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to the duration of total lactation.

Figure 2.

Mean percentage change from baseline ± SE in cortical thickness at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to the duration of total lactation.

*, Significant change compared with baseline for lactation group 4–8.9 months; §, significant change compared with baseline for lactation group 9 months or longer; ‡, significant change compared with baseline for lactation group 4–8.9 months. a, Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

Still at 18 months postpartum, cortical vBMD was significantly lower compared with baseline (−0.77% ± 0.17%) for women with the longest duration of lactation (≥9 mo), and trabecular thickness was significantly lower compared with baseline for women lactating both 4–8.9 and 9 months or longer (−2.25% ± 1.25% and −3.21% ± 1.41%) (Figure 3). In women lactating 4–8.9 months, cortical thickness (+1.90% ± 0.57%) and area (+1.99% ± 0.57%) were instead significantly higher compared with baseline as well as trabecular number (+2.31% ± 1.06%). In controls, significant changes were found only in trabecular vBMD (−2.38% ± 0.81%) and trabecular bone volume fraction (−2.45% ± 0.83%) at 18 months postpartum, as compared with baseline.

Mean percentage change from baseline ± SE in trabecular thickness at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to the duration of total lactation.

Figure 3.

Mean percentage change from baseline ± SE in trabecular thickness at the ultradistal tibia postpartum, as assessed with HR-pQCT in relation to the duration of total lactation.

§, Significant change compared with baseline for lactation groups 4–8.9 and 9 months or longer; ‡, significant change compared with baseline for lactation groups 4–8.9 and 9 months or longer. a, Because of the small number of women at 18 months postpartum in the group lactating 0–3.9 months, this measurement was excluded from all analyses.

Discussion

This study describes, using HR-pQCT measurements for the first time, compartmental changes in bone microstructural and dimensional parameters and vBMD during differing durations of lactation. The novelty of this study is that among women lactating 4 months or longer, we show that cortical vBMD, cortical thickness, and trabecular thickness at the ultradistal tibia decreased significantly during the first 12 months postpartum as compared with baseline. At 18 months postpartum, cortical vBMD as well as trabecular thickness was still significantly lower than at baseline in women lactating 9 months or longer. To our knowledge, no data on changes in vBMD or microstructural and dimensional parameters postpartum have previously been published. The strengths of our study are the inclusion of a control group and longitudinal measurements throughout and after lactation with an 18-month follow-up.

In accordance with previous studies (1, 35, 8, 9), we found significant bone decreases postpartum, especially in women with extended lactation. We also confirm previous results by showing that the decreases in aBMD are at first the most pronounced in the lumbar spine, whereas the decrease is more longlasting in the femoral neck (35, 11). At 18 months postpartum, significant decreases in aBMD compared with baseline were no longer found at any skeletal site for any lactation group in this study. Instead, the lumbar spine aBMD was significantly higher than baseline in all lactation groups at 18 months postpartum. This increase corresponds well with the decreases in aBMD at the lumbar spine during pregnancy previously reported by others (46, 10, 30). Hence, the higher values at 18 months postpartum compared with baseline probably reflects a recovery of the bone lost during pregnancy.

The HR-pQCT data showed that cortical vBMD, thickness, and area at the ultradistal tibia was markedly reduced during the first 12 months postpartum in women lactating 4 months or longer. Potentially the decreases in cortical thickness and area may be due to the trabecularization of the cortical bone or a result of increased porosity because of a high bone turnover state (31). Thus, it seems that lactation reduces both cortical bone quality and dimensional parameters, at least temporally. At 18 months postpartum, only cortical vBMD was significantly lower than baseline and only in women lactating 9 months or longer. Thus, the decrease in the cortical thickness and area is transient and is not observed approximately 6 months after weaning, whereas the effect of lactation is more persistent in the cortical vBMD. No decreases in cortical bone were found in women who lactated for less than 4 months or in controls.

Trabecular bone volume fraction and trabecular thickness decreased in women lactating 4 months or longer, with the nadir at 12 and 18 months, respectively. A decrease in trabecular bone volume fraction was also observed in controls. This makes the interpretation of these results difficult. No changes in trabecular bone parameters were found in women lactating for less than 4 months. Hence, we found an effect of lactation mainly on cortical vBMD, thickness, and area, but also on trabecular thickness in women lactating 4 months or longer, during the first 18 months postpartum.

The finding that cortical vBMD still at 18 months postpartum was lower than baseline in women with longest lactation also supports our findings from the DXA measurements, ie, that extended lactation has a long-lasting effect on the cortical-rich bone, such as the femoral neck. It further supports previous suggestions that an extended lactation causes the bone loss of the cortical-rich skeletal sites, as measured by DXA (4, 5, 11). However, the finding that trabecular thickness still was lower than baseline at 18 months postpartum in women lactating 4 months or longer indicates that a long lactation may also have a long-lasting effect on trabecular bone.

The findings of long-lasting decreases in cortical bone in women with extended lactation are especially interesting, considering that Swedish women in general have a long duration of lactation (21). Whether these decreases in vBMD, microstructural and dimensional parameters persist and may implicate increased risk of fracture in later life is unknown. However, Melton et al (24) showed among postmenopausal women that cortical and trabecular vBMD, cortical thickness and cortical area were major determinants of fracture risk. Thus, further investigations with follow-up periods longer than 18 months are needed to elucidate whether women with extended lactation fully recover their skeletal health after weaning. Recently Sawo et al (15) showed among Gambian women that successive periods of long lactation were not associated with persistent decreases in aBMD, which points toward the observation that a full recovery takes place also after an extended lactation.

One limitation of our study was the difficulty in recruiting formula-feeding women or women with a very short duration of lactation (≤3.9 mo). Another limitation was the study dropouts, which were mainly due to new pregnancies and which especially resulted in incomplete follow-up data for the group lactating 0–3.9 months at 18 months postpartum. Furthermore, the lack of prepregnancy values for bone parameters made it impossible to evaluate to what degree the women had recovered to their prepregnancy bone mineral density values after lactation. An additional limitation is that only measurements of the ultradistal tibia from the HR-pQCT were reported in this study.

The percentage of women in this study who were lactating at 4 months postpartum was 88%, compared with 76% in the whole country (21). Earlier studies have shown that women with a higher level of education breast-feed for a longer period than women with a lower level of education (32). In our study, 80% of the postpartum women and 71% of the controls had studied for 3 years or more at a university, which is a higher proportion than in the general population of women at the same age (37%) (33). The mean age in postpartum women was 32.9 years, which is slightly higher than comparable national data (34). The mean self-reported prepregnancy body weight in postpartum women was 64.1 kg and the mean measured body weight in controls at baseline was 63.4 kg, which are both lower than the values at the same age in the general population of 67.0 kg (35). Thus, the women in this study weigh less and have a higher education level than the general population, why the interpretation of the results has to be handled with care. Also, these women are possibly more health conscious, since they have actively chosen to participate in a longitudinal study.

In conclusion, decreased cortical vBMD and thickness and trabecular thickness at ultradistal tibia postpartum were found in women with a long lactation. At 18 months postpartum, the cortical vBMD and trabecular thickness were still lower than baseline in women lactating 9 months or longer. Longer follow-up periods are needed to confirm whether these changes could potentially lead to an increased risk of fracture in later life.

Acknowledgments

We thank all the volunteers. We also thank research nurse Ulrika Hjertonsson and Daniel Sundh for performing the bone measurements, laboratory assistant Elisabeth Gramatkovski and research nurse Anna Folino for help with the data collection and Dr Ann Laskey for valuable comments.

This work was supported by The Swedish Research Council Formas (Grants 2007–398 and 2009–1504), The Graduate School Environment and Health, The Swedish Nutrition Foundation, Willhelm and Martina Lundgren Foundation, Magnus Wiberg Foundation, Fredrik and Ingrid Thuring Foundation, Olof Johannisson Foundation, The Swedish Society of Medicine, Sahlgrenska University Hospital Foundation, and Gustaf V's and Queen Victoria's Freemason Foundation.

Disclosure Summary: The authors have nothing to disclose.

Abbreviations

References

Laskey

MA

,

Prentice

A

,

Hanratty

LA

, et al. .

Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin D-receptor genotype

.

Am J Clin Nutr

.

1998

;

67

:

685

692

.

Laskey

MA

,

Prentice

A

,

Shaw

J

, et al. .

Breast-milk calcium concentrations during prolonged lactation in British and rural Gambian mothers

.

Acta Paediatr Scand

.

1990

;

79

:

507

512

.

Sowers

M

,

Corton

G

,

Shapiro

B

, et al. .

Changes in bone density with lactation

.

JAMA

.

1993

;

269

:

3130

3135

.

Karlsson

C

,

Obrant

KJ

,

Karlsson

M

.

Pregnancy and lactation confer reversible bone loss in humans

.

Osteoporos Int

.

2001

;

12

:

828

834

.

Moller

UK

,

Vieth Streym

S

,

Mosekilde

L

,

Rejnmark

L

.

Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study

.

Osteoporos Int

.

2012

;

23

:

1213

1223

.

Drinkwater

BL

,

Chesnut

CH

3rd.

Bone density changes during pregnancy and lactation in active women: a longitudinal study

.

Bone Miner

.

1991

;

14

:

153

160

.

Holmberg-Marttila

D

,

Sievanen

H

,

Tuimala

R

.

Changes in bone mineral density during pregnancy and postpartum: prospective data on five women

.

Osteoporos Int

.

1999

;

10

:

41

46

.

Karlsson

MK

,

Ahlborg

HG

,

Karlsson

C

.

Maternity and bone mineral density

.

Acta Orthop

.

2005

;

76

:

2

13

.

Laskey

MA

,

Prentice

A

.

Bone mineral changes during and after lactation

.

Obstet Gynecol

.

1999

;

94

:

608

615

.

More

C

,

Bettembuk

P

,

Bhattoa

HP

,

Balogh

A

.

The effects of pregnancy and lactation on bone mineral density

.

Osteoporos Int

.

2001

;

12

:

732

737

.

Hopkinson

JM

,

Butte

NF

,

Ellis

K

,

Smith

EO

.

Lactation delays postpartum bone mineral accretion and temporarily alters its regional distribution in women

.

J Nutr

.

2000

;

130

:

777

783

.

Krebs

NF

,

Reidinger

CJ

,

Robertson

AD

,

Brenner

M

.

Bone mineral density changes during lactation: maternal, dietary, and biochemical correlates

.

Am J Clin Nutr

.

1997

;

65

:

1738

1746

.

Polatti

F

,

Capuzzo

E

,

Viazzo

F

,

Colleoni

R

,

Klersy

C

.

Bone mineral changes during and after lactation

.

Obstet Gynecol

.

1999

;

94

:

52

56

.

Kolthoff

N

,

Eiken

P

,

Kristensen

B

,

Nielsen

SP

.

Bone mineral changes during pregnancy and lactation: a longitudinal cohort study

.

Clin Sci (Lond)

.

1998

;

94

:

405

412

.

Sawo

Y

,

Jarjou

LM

,

Goldberg

GR

,

Laskey

MA

,

Prentice

A

.

Bone mineral changes after lactation in Gambian women accustomed to a low calcium intake

.

Eur J Clin Nutr

.

2013

;

67

:

1142

1146

.

Affinito

P

,

Tommaselli

GA

,

di Carlo

C

,

Guida

F

,

Nappi

C

.

Changes in bone mineral density and calcium metabolism in breastfeeding women: a one year follow-up study

.

J Clin Endocrinol Metab

.

1996

;

81

:

2314

2318

.

Tsvetov

G

,

Levy

S

,

Benbassat

C

,

Shraga-Slutzky

I

,

Hirsch

D

.

Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women

.

Maturitas

.

2014

;

77

:

249

254

.

Bjornerem

A

,

Ahmed

LA

,

Jorgensen

L

,

Stormer

J

,

Joakimsen

RM

.

Breastfeeding protects against hip fracture in postmenopausal women: the Tromso study

.

J Bone Miner Res

.

2011

;

26

:

2843

2850

.

Wiklund

PK

,

Xu

L

,

Wang

Q

, et al. .

Lactation is associated with greater maternal bone size and bone strength later in life

.

Osteoporos Int

.

2012

;

23

:

1939

1945

.

Sowers

M

,

Randolph

J

,

Shapiro

B

,

Jannausch

M

.

A prospective study of bone density and pregnancy after an extended period of lactation with bone loss

.

Obstet Gynecol

.

1995

;

85

:

285

289

.

The National Board of Health and Welfare

.

Breast-Feeding and Smoking Habits Among Parents of Infants Born in 2011

.

Stockholm

:

National Board of Health and Welfare

;

2013

.

Olausson

H

,

Goldberg

GR

,

Laskey

MA

,

Schoenmakers

I

,

Jarjou

LM

,

Prentice

A

.

Calcium economy in human pregnancy and lactation

.

Nutr Res Rev

.

2012

;

25

:

40

67

.

Kalkwarf

HJ

,

Specker

BL

.

Bone mineral loss during lactation and recovery after weaning

.

Obstet Gynecol

.

1995

;

86

:

26

32

.

Melton

LJ

3rd,

Riggs

BL

,

van Lenthe

GH

, et al. .

Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women

.

J Bone Miner Res

.

2007

;

22

:

1442

1448

.

World Health Organization

.

Declaration of Helsinki: ethical principles for medical research involving human subjects

.

Bull World Health Organ

.

2001

;

79

:

373

374

.

Rudang

R

,

Darelid

A

,

Nilsson

M

,

Mellstrom

D

,

Ohlsson

C

,

Lorentzon

M

.

X-ray-verified fractures are associated with finite element analysis-derived bone strength and trabecular microstructure in young adult men

.

J Bone Miner Res

.

2013

;

28

:

2305

2316

.

Nilsson

M

,

Ohlsson

C

,

Sundh

D

,

Mellstrom

D

,

Lorentzon

M

.

Association of physical activity with trabecular microstructure and cortical bone at distal tibia and radius in young adult men

.

J Clin Endocrinol Metab

.

2010

;

95

:

2917

2926

.

Burghardt

AJ

,

Pialat

JB

,

Kazakia

GJ

, et al. .

Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography

.

J Bone Miner Res

.

2013

;

28

:

524

536

.

Cole

TJ

.

Sympercents: symmetric percentage differences on the 100 log (e) scale simplify the presentation of log transformed data

.

Stat Med

.

2000

;

19

:

3109

3125

.

Olausson

H

,

Laskey

MA

,

Goldberg

GR

,

Prentice

A

.

Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake

.

Am J Clin Nutr

.

2008

;

88

:

1032

1039

.

Bjornerem

A

,

Ghasem-Zadeh

A

,

Bui

M

, et al. .

Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: a twin study

.

Bone

.

2011

;

49

:

1125

1130

.

Flacking

R

,

Nyqvist

KH

,

Ewald

U

.

Effects of socioeconomic status on breastfeeding duration in mothers of preterm and term infants

.

Eur J Public Health

.

2007

;

17

:

579

584

.

Statistics Sweden

.

Educational attainment of the population 2010

.

. Accessed April 23, 2013

Statistics Sweden

.

Äldre mammor vanligare förr

.

. Accessed April 23, 2013

Statistics Sweden

.

BMI, vikt och längd: medelvärden, 1988–1989, 2008–2011

.

. Accessed April 23, 2013

Copyright © 2015 by the Endocrine Society

Supplementary data

Citations

Views

Altmetric

Metrics

Total Views 1,513

1,043 Pageviews

470 PDF Downloads

Since 1/1/2017

Month: Total Views:
January 2017 2
February 2017 6
March 2017 4
April 2017 5
May 2017 5
June 2017 10
July 2017 3
August 2017 7
September 2017 1
October 2017 2
November 2017 5
December 2017 12
January 2018 19
February 2018 20
March 2018 12
April 2018 25
May 2018 17
June 2018 13
July 2018 17
August 2018 20
September 2018 14
October 2018 9
November 2018 12
December 2018 22
January 2019 2
February 2019 17
March 2019 9
April 2019 18
May 2019 18
June 2019 18
July 2019 11
August 2019 15
September 2019 16
October 2019 25
November 2019 15
December 2019 15
January 2020 23
February 2020 23
March 2020 15
April 2020 23
May 2020 15
June 2020 17
July 2020 16
August 2020 4
September 2020 12
October 2020 8
November 2020 19
December 2020 7
January 2021 12
February 2021 18
March 2021 24
April 2021 16
May 2021 21
June 2021 31
July 2021 11
August 2021 7
September 2021 22
October 2021 20
November 2021 20
December 2021 18
January 2022 33
February 2022 24
March 2022 25
April 2022 18
May 2022 8
June 2022 8
July 2022 18
August 2022 15
September 2022 13
October 2022 26
November 2022 15
December 2022 23
January 2023 25
February 2023 16
March 2023 31
April 2023 21
May 2023 21
June 2023 11
July 2023 17
August 2023 12
September 2023 31
October 2023 30
November 2023 29
December 2023 17
January 2024 17
February 2024 16
March 2024 23
April 2024 27
May 2024 15
June 2024 11
July 2024 24
August 2024 26
September 2024 17
October 2024 7

Citations

43 Web of Science

×

Email alerts

More on this topic

Citing articles via

More from Oxford Academic